Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose-the PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial.

Name: Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose-the PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial.
Author: Dear, James

Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose-the PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial. — المؤلف: Dear, James — Trials 20190528

المؤلف: Dear, James
النشر: Trials 20190528
الوصف: 27 p.
الموضوعات: Acetaminophen؛ Acetylcysteine؛ Chemical and Drug Induced Liver Injury؛ Clinical Trials Data Monitoring Committees؛ Clinical Trials, Phase I as Topic؛ Data Interpretation, Statistical؛ Drug Overdose؛ Drug Therapy, Combination